... A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases. Journal of TranslationalMedicine 2011 9:43.Submit ... combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant casesChong Xie1, Hyun J Kim2, Jonathan G Haw3, Anusha Kalbasi3, Brian K Gardner4, ... monoclonal Abagainst human PSA (Biocon, Inc. Rockville, MD) toquantify total PSA levels. sero MAP-based PSA quantifi-cation was compared with standard ELISA-based PSA assays (American Qualex) and...